1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-24231
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKopanska, Katarzyna S-
dc.contributor.authorRimann, Markus-
dc.date.accessioned2022-02-10T15:24:45Z-
dc.date.available2022-02-10T15:24:45Z-
dc.date.issued2022-
dc.identifier.issn1868-596Xde_CH
dc.identifier.issn1868-8551de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/24231-
dc.description.abstractRecent advances in microphysiological systems (MPS) promise a global paradigm shift in drug development, diagnostics, disease prevention, and therapy. The expectation is that these systems will model healthy and various diseased stages and disease progression to predict toxicity, immunogenicity, ADME profiles, and treatment efficacies. MPS will provide unprecedented human-like physiological properties of in vitro models, enabling their routine application in the pharma industry and thus reducing drug development costs by lowering the attrition rate of compounds. We showcased MPS application diversity across different industries during the TEDD Annual Meeting on 14th October 2021 in Wädenswil, Switzerland. The goal was to promote cross-sectoral collaboration of academia and industry to further pave the way for developing next-generation MPS based on 3D cell culture, organoid, and organ-on-chip technology and their widespread exploitation. To enable visionary projects and radical innovations, we covered multidisciplinary fields and connected different industry sectors, like pharma, medtech, biotech, cosmetics, diagnostics, fragrances, and food, with each other.de_CH
dc.language.isoende_CH
dc.publisherSpringerde_CH
dc.relation.ispartofALTEX - Alternatives to Animal Experimentationde_CH
dc.rightshttps://creativecommons.org/licenses/by/4.0/de_CH
dc.subjectMicrophysiological systemde_CH
dc.subjectCross-sectoral collaborationde_CH
dc.subject3D cell culturede_CH
dc.subjectDrug developmentde_CH
dc.subjectHuman-relevant test systemde_CH
dc.subjectAlternative methodde_CH
dc.subjectLab-On-A-Chip devicede_CH
dc.subject3Rs principlede_CH
dc.subjectBiofabricationde_CH
dc.subject.ddc610.28: Biomedizin, Biomedizinische Technikde_CH
dc.titleCross-industrial applications of organotypic modelsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.14573/altex.2112202de_CH
dc.identifier.doi10.21256/zhaw-24231-
dc.identifier.pmid35034134de_CH
zhaw.funding.euNode_CH
zhaw.issue1de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end158de_CH
zhaw.pages.start155de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume39de_CH
zhaw.publication.reviewKeine Begutachtungde_CH
zhaw.webfeed3D Gewebe und Biofabrikationde_CH
zhaw.funding.zhaw3D Gewebe TEDDde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2022_Kopanska-Rimann_Cross-industrial-applications-organotypic-models.pdf1.03 MBAdobe PDFThumbnail
View/Open
Show simple item record
Kopanska, K. S., & Rimann, M. (2022). Cross-industrial applications of organotypic models. ALTEX - Alternatives to Animal Experimentation, 39(1), 155–158. https://doi.org/10.14573/altex.2112202
Kopanska, K.S. and Rimann, M. (2022) ‘Cross-industrial applications of organotypic models’, ALTEX - Alternatives to Animal Experimentation, 39(1), pp. 155–158. Available at: https://doi.org/10.14573/altex.2112202.
K. S. Kopanska and M. Rimann, “Cross-industrial applications of organotypic models,” ALTEX - Alternatives to Animal Experimentation, vol. 39, no. 1, pp. 155–158, 2022, doi: 10.14573/altex.2112202.
KOPANSKA, Katarzyna S und Markus RIMANN, 2022. Cross-industrial applications of organotypic models. ALTEX - Alternatives to Animal Experimentation. 2022. Bd. 39, Nr. 1, S. 155–158. DOI 10.14573/altex.2112202
Kopanska, Katarzyna S, and Markus Rimann. 2022. “Cross-Industrial Applications of Organotypic Models.” ALTEX - Alternatives to Animal Experimentation 39 (1): 155–58. https://doi.org/10.14573/altex.2112202.
Kopanska, Katarzyna S., and Markus Rimann. “Cross-Industrial Applications of Organotypic Models.” ALTEX - Alternatives to Animal Experimentation, vol. 39, no. 1, 2022, pp. 155–58, https://doi.org/10.14573/altex.2112202.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.